Finding A Glass Slipper Service Provider To Fit Your Phase II/III Outsourcing Needs

How would you outsource your Phase II/III research needs if you were the only person making the decision? Market Research Director at Industry Standard Research Sherry Hubbard-Bednasz discusses how ISR uses that question to gauge service provider quality and performance. “Such decisions are rarely made by a single individual; however, an aggregate measure of provider … Continued

Message To CROs: Keep That Pandemic Tool Belt Handy

Over the past year, the pharma industry has been in overdrive. The best of the best around the world – biochemists, scientists, doctors, researchers, and the like – came together to develop a COVID-19 vaccine in record time. Several vaccines have been approved for emergency authorization; manufacturing, distribution, and inoculation efforts are happening at rates … Continued

Too Hot, Too Cold – Finding the Clinical Development Outsourcing Model That Is Just Right

Market Research Director at Industry Standard Research Sherry Hubbard-Bednasz takes a look at the clinical outsourcing models most preferred by outsourcers, and why those models work best for their proponents. “Let’s say you are sponsoring a novel clinical study that requires therapeutic expertise not available in-house, specific geographies, and remote/risk-based monitoring. In the past, this … Continued

Warming Up To Hybrid Trials

Vice President of Market Research at Industry Standard Research Rebecca McAvoy analyzes results from a recent study indicating that COVID-19 has made sponsors more willing to run hybrid trials. “In a November 2020 survey, Industry Standard Research (ISR) asked 121 clinical trials outsourcers at sponsor companies a series of questions about their company’s use of … Continued